Organization and Description of Business (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Jan. 27, 2023	Dec. 31, 2022	Jul. 12, 2022
Subsidiary, Sale of Stock [Line Items]
Accumulated deficit	$ 716,108		$ 601,860
Cash and cash equivalents and short-term investments	$ 281,300
Sufficient funding term (at least)	12 months
At-the-market
Subsidiary, Sale of Stock [Line Items]
Sale of stock, consideration receivable (up to)		$ 125,000		$ 350,000
Shares sold in offering (in shares)	2,040,816
Aggregate net proceeds from shares sold	$ 14,600